The International CAA Association (ICAAA) was founded in 2014 with the goal of improving scientific understanding, diagnosis, and treatment of cerebral amyloid angiopathy (CAA). The ICAAA is comprised of leading clinicians and scientists in the CAA field drawn from medical centers and universities around the world. The ICAAA organizes bi-annual scientific meetings of the international CAA community, collaborative research projects, and consensus guidelines, all aimed at improving the condition of individuals suffering from this increasingly recognized disease of the brain’s small blood vessels.
Board Members:
Steven M. Greenberg, MD PhD - Chairman
Massachusetts General Hospital / Harvard Medical School, Boston, MA, USA
Mark A. van Buchem, MD PhD - Secretary
Leiden University Medical Center, the Netherlands
Charlotte Cordonnier, MD PhD - Treasurer
Lille University, France
Eric E. Smith, MD
University of Calgary, Canada
Susanne J. van Veluw, PhD
Massachusetts General Hospital / Harvard Medical School, Boston, MA, USA Leiden University Medical Center, the Netherlands